Hideto Morimoto

A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II

Hiroyuki Sonoda, Hideto Morimoto, Eiji Yoden et al. · Molecular Therapy · 2018 · 202 citations · Full text

Life Sciences, Neurology, Neuroscience +13

Glycosaminoglycans in Hydra magnipapillata (Hydrozoa, Cnidaria): demonstration of chondroitin in the developing nematocyst, the sting organelle, and structural characterization of glycosaminoglycans

Shuhei Yamada, Hideto Morimoto, Toshitaka Fujisawa et al. · Glycobiology · 2007 · 62 citations · Full text

Life Sciences, Biochemistry, Developmental Biology +17

Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II

Takashi Higuchi, Hiromi Shimizu, Takahiro Fukuda et al. · Molecular Genetics and Metabolism · 2012 · 46 citations

Medicine, Neurology, Neuropathology +2

Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS

Noboru Tanaka, Sachiho Kida, Masafumi Kinoshita et al. · Molecular Genetics and Metabolism · 2018 · 44 citations · Full text

Medicine, Neurobiology, Neurology +17

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data

Roberto Giugliani, Ana Maria Martins, Torayuki Okuyama et al. · International Journal of Molecular Sciences · 2021 · 44 citations · Full text

Medicine, Neurology, Pharmacology +17